Immunotherapeutic potential of CpG oligodeoxynucleotides in veterinary species

Author： Manuja Anju   Manuja Balvinder K.   Kaushik Jyoti   Singha Harisankar   Singh Raj Kumar  

Publisher： Informa Healthcare

ISSN： 0892-3973

Source： Immunopharmacology and Immunotoxicology, Vol.35, Iss.5, 2013-10, pp. : 535-544

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

CpG oligodeoxynucleotides: postexposure prophylaxis for prion diseases?

By  

Inpharma, Vol. 1, Iss. 1348, 2002-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

CpG Oligodeoxynucleotides: A Novel Therapeutic Approach For Atopic Disorders

By  

Current Drug Targets. Inflammation & Allergy, Vol. 2, Iss. 3, 2003-09 ,pp. : 199-205

Bentham Science Publishers

Access to resources Recommend Favorite

A Review of the Role of CpG Oligodeoxynucleotides as Toll-Like Receptor 9 Agonists in Prophylactic and Therapeutic Vaccine Development in Infectious Diseases

By Gupta Kaveri  

Drugs in R&D, Vol. 9, Iss. 3, 2008-01 ,pp. : 137-145

Adis International

Access to resources Recommend Favorite

Synthetic Oligodeoxynucleotides Containing Deoxycytidyl-Deoxyguanosine Dinucleotides (CpG ODNs) and Modified Analogs as Novel Anticancer Therapeutics

By  

Current Pharmaceutical Design, Vol. 11, Iss. 22, 2005-08 ,pp. : 2889-2907

Bentham Science Publishers

Access to resources Recommend Favorite

Intramammary Application of Non-Methylated-CpG Oligodeoxynucleotides (CpG) Inhibits both Local and Systemic Mammary Carcinogenesis in Female BALB/c Her-2/neu Transgenic Mice

By  

Current Cancer Drug Targets, Vol. 8, Iss. 3, 2008-05 ,pp. : 230-242

Bentham Science Publishers

Access to resources Recommend Favorite